Orchid Pharma Limited (NSE:ORCHPHARMA)
India · Delayed Price · Currency is INR 990.85
-25.25 (-2.48%)
Sep 11, 2026, 3:29 PM IST
Orchid Pharma Market Cap
Orchid Pharma has a market cap or net worth of 50.87 billion as of September 11, 2026. Its market cap has increased by 40.37% in one year.
Market Cap
50.87B
Enterprise Value
53.67B
Revenue
8.52B
Ranking
n/a
PE Ratio
172.54
Stock Price
990.85
ChartMarket Cap Chart
Since November 3, 2020, Orchid Pharma's market cap has increased from 727.35M to 50.87B, an increase of 6,894.42%. That is a compound annual growth rate of 106.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 50.87B | 32.16% |
| Dec 31, 2025 | 38.49B | -58.00% |
| Dec 31, 2024 | 91.65B | 153.62% |
| Dec 29, 2023 | 36.14B | 143.20% |
| Dec 30, 2022 | 14.86B | -7.81% |
| Dec 31, 2021 | 16.12B | 223.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Akums Drugs and Pharmaceuticals | 114.77B |
| Strides Pharma Science | 109.08B |
| Aarti Pharmalabs | 74.97B |
| Innova Captab | 65.65B |
| Sun Pharma Advanced Research Company | 63.90B |
| RPG Life Sciences | 46.02B |
| Solara Active Pharma Sciences | 36.15B |
| Ind-Swift Laboratories | 32.83B |